Metraipolis › archive › dc_2e7389bc3c4e

JAK Inhibitors for Crohn's Disease: A Systematic Review and Dose-Response Network Meta-Analysis of Efficacy and Safety — Europe PMC PMID:42022940

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42022940
DOI
10.1002/jgh3.70388
License (as archived)
solo-consultazione
Archived
2026-11-04T10:05:49.441Z
SHA-256 of the archived text
5beb1f1851e413f7f6432da51d8408e3a530effd129e437c88a3eafabf2838e8
Stable URL of this page
https://metraipolis.com/documento/dc_2e7389bc3c4e

How to cite

JAK Inhibitors for Crohn's Disease: A Systematic Review and Dose-Response Network Meta-Analysis of Efficacy and Safety — Europe PMC PMID:42022940 — Europe PMC (en), https://europepmc.org/article/MED/42022940 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2e7389bc3c4e (Metraipolis archive dc_2e7389bc3c4e, sha256 5beb1f1851e413f7f6432da51d8408e3a530effd129e437c88a3eafabf2838e8)
BibTeX
@misc{dc2e7389bc3c4e,
  title = {JAK Inhibitors for Crohn's Disease: A Systematic Review and Dose-Response Network Meta-Analysis of Efficacy and Safety — Europe PMC PMID:42022940},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42022940},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2e7389bc3c4e; sha256 5beb1f1851e413f7f6432da51d8408e3a530effd129e437c88a3eafabf2838e8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42022940. Agents can read the archived copy with the MCP tool read_document.